TMCnet News

AEterna Zentaris Up 5.2%, Shares Break Through Resistance (AEZS)
[January 28, 2013]

AEterna Zentaris Up 5.2%, Shares Break Through Resistance (AEZS)


Jan 28, 2013 (SmarTrend(R) Spotlight via COMTEX) -- AEterna Zentaris (NASDAQ:AEZS) is one of today's best performing low-priced stocks, up 5.2% to $2.73 on 1.1x average daily volume. Thus far today, AEterna Zentaris has traded 922,000 shares, vs. average volume of 823,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's -0.1%) and outperformed the S&P 500 (5.2% to the S&P's -0.1%) during today's trading.



AEterna Zentaris Inc is a biopharmaceutical company focused in oncology and endocrine therapy. The Company's portfolio includes an orally-active inhibitor for multiple cancers, as well a product marketed for in vitro fertilization. AEterna Zentaris also develops and sells active ingredients, specialty chemicals, cosmetic, and nutritional products.

Potential upside of 80.4% exists for AEterna Zentaris, based on a current level of $2.73 and analysts' average consensus price target of $4.92. The stock should find initial support at its 50-day moving average (MA) of $2.32 and further support at its 200-day MA of $1.21.


In the past 52 weeks, AEterna Zentaris share prices have been bracketed by a low of $0.38 and a high of $3.55 and are now at $2.73, 617% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.5% while the 200-day MA has risen 3.1%.

SmarTrend recommended that subscribers consider buying shares of AEterna Zentaris on December 28th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $2.49. Since that recommendation, shares of AEterna Zentaris have risen 4.2%. We continue to monitor AEZS for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To TMCnet.com's Homepage ]